KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Inventory (2016 - 2025)

Biogen (BIIB) has 17 years of Change in Inventory data on record, last reported at $29.4 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 55.72% year-over-year to $29.4 million; the TTM value through Dec 2025 reached $64.7 million, down 76.37%, while the annual FY2025 figure was $64.7 million, 76.37% down from the prior year.
  • Change in Inventory reached $29.4 million in Q4 2025 per BIIB's latest filing, up from $7.4 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $142.6 million in Q1 2022 and bottomed at -$62.0 million in Q1 2025.
  • Average Change in Inventory over 5 years is $62.6 million, with a median of $85.6 million recorded in 2021.
  • Peak YoY movement for Change in Inventory: skyrocketed 630.39% in 2023, then tumbled 179.79% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $139.8 million in 2021, then crashed by 112.95% to -$18.1 million in 2022, then surged by 630.39% to $96.0 million in 2023, then plummeted by 30.83% to $66.4 million in 2024, then plummeted by 55.72% to $29.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $29.4 million in Q4 2025, $7.4 million in Q3 2025, and $89.9 million in Q2 2025.